Close
  Indian J Med Microbiol
 

Figure 1: The different imaging modalities in a 42-year-old man with a radioiodine-refractory differentiated thyroid cancer. Computed tomography scan of thorax (a); post131I ablation whole-body scan (b);99mTc octreotide scintigraphy (c); post177Lu-DOTATATE whole-body imaging (d); 2 and 24 h prostate-specific membrane antigen scintigraphy (e and f) and post177Lu-prostate-specific membrane antigen whole-body imaging (g)

Figure 1: The different imaging modalities in a 42-year-old man with a radioiodine-refractory differentiated thyroid cancer. Computed tomography scan of thorax (a); post<sup>131</sup>I ablation whole-body scan (b);<sup>99m</sup>Tc octreotide scintigraphy (c); post<sup>177</sup>Lu-DOTATATE whole-body imaging (d); 2 and 24 h prostate-specific membrane antigen scintigraphy (e and f) and post<sup>177</sup>Lu-prostate-specific membrane antigen whole-body imaging (g)